Suggested Search Terms
The Pharmacy First started on 31st January 2024. Pharmacists can give you advice on a range of conditions and suggest medicines that can help. They may also be able to offer treatment and some prescription medicine for some conditions, without you needing to see a GP (this is called Pharmacy First). Conditions they can treat as part of Pharmacy First are: earache (aged 1 to 17 years) impetigo (aged 1 year and over) infected insect bites (aged 1 year and over) shingles (aged 18 years and over) sinusitis (aged 12 years and over) sore throat (aged 5 years and over) urinary tract infections or UTIs (women aged 16 to 64 years) If you go to a pharmacy with one of these conditions, the pharmacist will offer you advice, treatment or refer you to a GP or other healthcare professional if needed. They will then update your GP health record. If you are not within these age ranges, a pharmacist can still offer advice, but you may need to see a GP for treatment.
The Department of Health and Social Care (DHSC) has announced that from 1st May 2024, the NHS prescription charge will increase to £9.90 per prescription item (note: some items may incur more than one charge). For prescriptions dispensed in April 2024, the NHS prescription charge will remain at £9.65. Amendments to the NHS Charges Regulations also introduce increases to prescription prepayment certificates (PPCs), including the Hormone Replacement Therapy (HRT) PPC.
These days, getting an appointment to see your GP is getting harder and harder. But here’s some good news: your local pharmacist can now help…
If you haven’t already completed and submitted your pharmacy data security and protection toolkit please do so before the 30th June, try not to leave…
Pharmacy Contraception Service Opt in via MYS by 29th February 2024, if you have previously delivered the Tier 1 service and are now ready to…
New Original Pack Dispensing (OPD) rules, central procurement of certain vaccinations for community pharmacies, and changes to the market entry application process are being introduced…
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued precautionary guidance regarding the of use of valproate in men. This follows results from a…
In response to a significant ongoing disruption to the supply of some Isosorbide mononitrate 60mg modified-release preparations, four new Serious Shortage Protocols (SSPs) have been…
